Protara Therapeutics Inc (TARA)
2.99
-0.75
(-20.05%)
USD |
NASDAQ |
May 20, 16:00
2.99
0.00 (0.00%)
After-Hours: 20:00
Protara Therapeutics Stock Buybacks (Quarterly): 0.076M for March 31, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.076M |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.027M |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.064M |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.018M |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.072M |
Date | Value |
---|---|
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.228M |
December 31, 2020 | 0.001M |
September 30, 2020 | -73.57M |
June 30, 2020 | 0.00 |
March 31, 2020 | -14.28M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-73.57M
Minimum
Sep 2020
0.228M
Maximum
Mar 2021
-5.139M
Average
--
Median
Jun 2020
Stock Buybacks (Quarterly) Benchmarks
AngioDynamics Inc | -- |
Regulus Therapeutics Inc | -93.93M |
Bio-Path Holdings Inc | -0.174M |
Outset Medical Inc | -- |
NovaBay Pharmaceuticals Inc | -- |